Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion

Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion

We report the case of a 25-year-old women suffering from major depression who was treated with citalopram for several weeks with doses between 20 mg and 60 mg. She gradually developed marked mydriasis within 2 months after treatment and subsequently neuritis nervi optici. Moreover, abrupt galactorrh...

Full description

Bibliographic Details
Main Authors: Horst J. Koch, Heike Zellmer
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2011/191735
id doaj-692f0ddb3cac420190d62d95288eaf94
record_format Article
spelling doaj-692f0ddb3cac420190d62d95288eaf942020-11-25T00:32:53ZengHindawi LimitedCase Reports in Medicine1687-96271687-96352011-01-01201110.1155/2011/191735191735Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and DiscussionHorst J. Koch0Heike Zellmer1Department of Psychiatry and Psychotherapy, HELIOS Clinic Aue, D-08280 Aue, GermanyDepartment of Psychiatry and Psychotherapy, HELIOS Clinic Aue, D-08280 Aue, GermanyWe report the case of a 25-year-old women suffering from major depression who was treated with citalopram for several weeks with doses between 20 mg and 60 mg. She gradually developed marked mydriasis within 2 months after treatment and subsequently neuritis nervi optici. Moreover, abrupt galactorrhea occurred after 2 months of treatment. All neuro-ophthalmological, neurophysiological, clinical laboratory, and neuroradiological diagnostic efforts did not reveal an underlying organic pathophysiology. The ocular symptoms disappeared rapidly after the discontinuation of citalopram and pulse therapy with methyl-prednisolone. However, galactorrhea persisted for a few weeks necessitating treatment with bromocriptine.http://dx.doi.org/10.1155/2011/191735
collection DOAJ
language English
format Article
sources DOAJ
author Horst J. Koch
Heike Zellmer
spellingShingle Horst J. Koch
Heike Zellmer
Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
Case Reports in Medicine
author_facet Horst J. Koch
Heike Zellmer
author_sort Horst J. Koch
title Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
title_short Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
title_full Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
title_fullStr Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
title_full_unstemmed Marked Mydriasis and Neuritis Nervi Optici Associated with Galactorrhea Following Citalopram Treatment: A Case Report and Discussion
title_sort marked mydriasis and neuritis nervi optici associated with galactorrhea following citalopram treatment: a case report and discussion
publisher Hindawi Limited
series Case Reports in Medicine
issn 1687-9627
1687-9635
publishDate 2011-01-01
description We report the case of a 25-year-old women suffering from major depression who was treated with citalopram for several weeks with doses between 20 mg and 60 mg. She gradually developed marked mydriasis within 2 months after treatment and subsequently neuritis nervi optici. Moreover, abrupt galactorrhea occurred after 2 months of treatment. All neuro-ophthalmological, neurophysiological, clinical laboratory, and neuroradiological diagnostic efforts did not reveal an underlying organic pathophysiology. The ocular symptoms disappeared rapidly after the discontinuation of citalopram and pulse therapy with methyl-prednisolone. However, galactorrhea persisted for a few weeks necessitating treatment with bromocriptine.
url http://dx.doi.org/10.1155/2011/191735
work_keys_str_mv AT horstjkoch markedmydriasisandneuritisnerviopticiassociatedwithgalactorrheafollowingcitalopramtreatmentacasereportanddiscussion
AT heikezellmer markedmydriasisandneuritisnerviopticiassociatedwithgalactorrheafollowingcitalopramtreatmentacasereportanddiscussion
_version_ 1725318514462425088

Similar Items